All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
At the 24th Congress of the European Hematology Association (EHA), Dr Zinaida Peric from the University of Zagreb School of Medicine, Zagreb, HR, outlines the need for a multidisciplinary approach to chronic GvHD (cGVHD) management. This approach is necessary to improve the quality-of-life of patients with GvHD. Dr Peric and colleagues implemented this method of patient care in their center, based on the NIH GvHD Consensus Criteria.
Clinical practice in chronic GvHD
Your opinion matters
Editorial Theme | Novel therapies for the treatment of GvHD
Currently, there are only two approved treatments for GvHD: ruxolitinib, indicated for steroid resistant (SR) aGvHD, and ibrutinib, used in patients with cGvHD who have failed one or more...
An overview of EBMT recommendations on prophylaxis and treatment of acute and chronic GvHD
A summary of the European Society for Blood and Marrow Transplantation (EBMT) webinar entitled ‘Prophylaxis and management of GvHD’ delivered by Olaf Penack on...
Subscribe to get the best content related to GvHD delivered to your inbox